Dan Irwin

1.1k total citations
7 papers, 889 citations indexed

About

Dan Irwin is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Dan Irwin has authored 7 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Virology and 2 papers in Infectious Diseases. Recurrent topics in Dan Irwin's work include HIV Research and Treatment (5 papers), RNA Research and Splicing (4 papers) and RNA and protein synthesis mechanisms (3 papers). Dan Irwin is often cited by papers focused on HIV Research and Treatment (5 papers), RNA Research and Splicing (4 papers) and RNA and protein synthesis mechanisms (3 papers). Dan Irwin collaborates with scholars based in United States, Japan and Germany. Dan Irwin's co-authors include B. Matija Peterlin, Koh Fujinaga, Ran Taube, Tetsutaro Sata, Kenzo Tokunaga, Yong‐Hui Zheng, Ye-Hong Huang, Xin Lin, Matthias Geyer and S. Kanazawa and has published in prestigious journals such as Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Dan Irwin

7 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Irwin United States 7 570 472 289 241 190 7 889
Nicole Rougeau Canada 14 809 1.4× 488 1.0× 460 1.6× 303 1.3× 197 1.0× 16 1.0k
John S. Albin United States 12 594 1.0× 333 0.7× 364 1.3× 237 1.0× 252 1.3× 21 830
B. Berkhout Netherlands 20 624 1.1× 729 1.5× 316 1.1× 225 0.9× 89 0.5× 24 1.1k
Isabelle Agostini France 10 481 0.8× 342 0.7× 350 1.2× 139 0.6× 124 0.7× 10 660
Meijuan Niu Canada 19 752 1.3× 672 1.4× 427 1.5× 198 0.8× 249 1.3× 34 1.2k
Jason L. DeHart United States 11 461 0.8× 346 0.7× 230 0.8× 281 1.2× 155 0.8× 12 728
Adewunmi Onafuwa-Nuga United States 9 546 1.0× 234 0.5× 280 1.0× 262 1.1× 129 0.7× 10 740
Loïc Dragin France 5 519 0.9× 247 0.5× 207 0.7× 391 1.6× 196 1.0× 6 746
Hongzhan Xu United States 7 596 1.0× 302 0.6× 370 1.3× 188 0.8× 343 1.8× 8 834
April J. Schumacher United States 8 474 0.8× 339 0.7× 273 0.9× 195 0.8× 387 2.0× 10 827

Countries citing papers authored by Dan Irwin

Since Specialization
Citations

This map shows the geographic impact of Dan Irwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Irwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Irwin more than expected).

Fields of papers citing papers by Dan Irwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Irwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Irwin. The network helps show where Dan Irwin may publish in the future.

Co-authorship network of co-authors of Dan Irwin

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Irwin. A scholar is included among the top collaborators of Dan Irwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Irwin. Dan Irwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Zheng, Yong‐Hui, et al.. (2004). Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication. Journal of Virology. 78(11). 6073–6076. 369 indexed citations
2.
Lin, Xin, Dan Irwin, S. Kanazawa, et al.. (2003). Transcriptional Profiles of Latent Human Immunodeficiency Virus in Infected Individuals: Effects of Tat on the Host and Reservoir. Journal of Virology. 77(15). 8227–8236. 79 indexed citations
3.
Fujinaga, Koh, et al.. (2003). Dynamics of Human Immunodeficiency Virus Transcription: P-TEFb Phosphorylates RD and Dissociates Negative Effectors from the Transactivation Response Element. Molecular and Cellular Biology. 24(2). 787–795. 277 indexed citations
4.
Taube, Ran, Xin Lin, Dan Irwin, Koh Fujinaga, & B. Matija Peterlin. (2002). Interaction between P-TEFb and the C-Terminal Domain of RNA Polymerase II Activates Transcriptional Elongation from Sites Upstream or Downstream of Target Genes. Molecular and Cellular Biology. 22(1). 321–331. 94 indexed citations
5.
Fujinaga, Koh, Dan Irwin, Matthias Geyer, & B. Matija Peterlin. (2002). Optimized Chimeras between Kinase-Inactive Mutant Cdk9 and Truncated Cyclin T1 Proteins Efficiently Inhibit Tat Transactivation and Human Immunodeficiency Virus Gene Expression. Journal of Virology. 76(21). 10873–10881. 24 indexed citations
6.
Fujinaga, Koh, Dan Irwin, Ran Taube, et al.. (2002). A Minimal Chimera of Human Cyclin T1 and Tat Binds TAR and Activates Human Immunodeficiency Virus Transcription in Murine Cells. Journal of Virology. 76(24). 12934–12939. 13 indexed citations
7.
Taube, Ran, et al.. (2000). Interactions between Equine Cyclin T1, Tat, and TAR Are Disrupted by a Leucine-to-Valine Substitution Found in Human Cyclin T1. Journal of Virology. 74(2). 892–898. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026